Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06349408 |
| Title | IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Innovent Biologics (Suzhou) Co. Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Wollongong Public | RECRUITING | Wollongong | New South Wales | 2500 | Australia | Details |
| Cancer Research SA | RECRUITING | Adelaide | South Australia | 5000 | Australia | Details |
| Chinese PLA General Hospital | NOT_YET_RECRUITING | Beijing | Beijing Municipality | 100853 | China | Details |
| Shanghai East Hospital | NOT_YET_RECRUITING | Shanghai | Shanghai Municipality | 200120 | China | Details |
| The First Affiliated Hospital of zhejiang University School of Medicine | NOT_YET_RECRUITING | Hangzhou | Zhejiang | 310003 | China | Details |